| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |